Our results also suggested that CCL14 exerts its regulatory effects on proliferation of HCC cells through the Wnt/β-catenin pathway by the treatment of DKK1, the specific inhibitor of Wnt/β-catenin pathways. Here, DKK1 is linked to hepatocellular carcinoma.